In our latest Insight from the Experts podcast, NFP's Head of Innovation, Mark Rieder, sits down with Jason Hellickson, CEO of Regenexx, to discuss their proprietary orthobiologic procedures that have created a new medical specialty platform called interventional orthopedics. This orthopedic healthcare innovation is less costly, less invasive and less risky than traditional orthopedic surgery.

Planned orthopedic surgery costs have increased 44% in eight years and are constantly in the top 10 of employer spend within their health plans. Interventional orthopedics can offer employees a choice and greatly reduce orthopedic spend on individual procedures that they choose a majority of the time.